Starting Isosorbide Mononitrate (Imdur) After Abnormal Stress Test
For a patient with an abnormal stress test indicating coronary ischemia, start isosorbide mononitrate at 30-60 mg once daily in the morning, then titrate upward to 120 mg once daily if symptoms persist after 2-4 weeks. 1, 2, 3, 4, 2
Initial Dosing Strategy
The ACC/AHA guidelines provide clear dosing parameters for oral isosorbide mononitrate in patients with coronary ischemia:
- Starting dose: 20 mg twice daily (for immediate-release) OR 60 mg once daily (for extended-release formulations like Imdur) 1, 2, 3, 4, 2
- Maximum dose: 240 mg once daily for extended-release preparations 1, 2, 3, 4, 2
For extended-release isosorbide mononitrate (Imdur), the most practical approach is:
- Begin with 60 mg once daily in the morning 5, 6
- This provides 12-hour antianginal coverage during waking hours while allowing a nitrate-free interval overnight to prevent tolerance 5, 6
Titration Protocol
Week 0-2: Start 60 mg once daily in the morning
- Assess symptom control and tolerability
- Most common side effect is headache, which typically resolves within days 7, 5
Week 2-4: If symptoms persist, increase to 120 mg once daily
- This dose demonstrates sustained efficacy at 4 and 12 hours post-dosing without tolerance development 5
- 120 mg maintains statistical superiority over placebo at 6 weeks 5
Week 4-6: If needed, escalate to 240 mg once daily maximum
- Reserve for refractory symptoms
- Both 120 mg and 240 mg doses maintain efficacy without tolerance at 6 weeks 5
Critical Timing Considerations
Morning administration is essential to provide daytime symptom control while preserving a nitrate-free interval overnight (approximately 12 hours). This prevents the development of nitrate tolerance that occurs with continuous 24-hour exposure 5, 6. The extended-release formulation provides:
- Onset of action: 1 hour post-dose 1, 2, 3, 4, 2
- Peak effect: 4 hours post-dose 5
- Duration: 12-24 hours 1, 2, 3, 4, 2
Contraindications and Precautions
Absolute contraindications:
- Systolic blood pressure <90 mm Hg or >30 mm Hg below baseline 1, 2, 3, 4, 2
- Phosphodiesterase inhibitor use within 24 hours (sildenafil), 48 hours (tadalafil), or 24 hours (vardenafil) 1, 2, 3, 4, 2
- Right ventricular infarction (common with inferior MI) 8
- Hypertrophic obstructive cardiomyopathy 9
Monitor blood pressure closely: Avoid titrating systolic BP below 110 mm Hg in normotensive patients or >25% reduction in mean arterial pressure in hypertensive patients 1, 2, 3, 4, 2.
Combination Therapy Considerations
Isosorbide mononitrate should be part of comprehensive antianginal therapy:
- First-line agents: Beta-blockers and/or calcium channel blockers 10, 9
- Add nitrates when initial therapy is inadequate, not tolerated, or contraindicated 10
- Concurrent beta-blocker use is beneficial as it counteracts reflex tachycardia from nitrate-induced vasodilation 1, 3, 4
Common Pitfalls to Avoid
Twice-daily dosing of extended-release formulations: This causes tolerance development. Once-daily morning dosing is mandatory 6
Abrupt discontinuation: May cause rebound angina exacerbation. Taper over several days if stopping 7
Inadequate nitrate-free interval: Continuous 24-hour nitrate exposure leads to tolerance within 7-8 hours 1, 2, 3, 4, 2
Underdosing: The 30 mg dose loses statistical significance versus placebo by 6 weeks; 60 mg is the minimum effective long-term dose, with 120-240 mg preferred for sustained benefit 5
Reassessment Timeline
Evaluate response at 2-4 weeks after each dose adjustment 10. If symptoms remain inadequately controlled on maximum medical therapy (including 120-240 mg isosorbide mononitrate), consider revascularization rather than further medication adjustments 10.